Xironetic
PrivateLast Round
Grant
May 9, 2024
Total Funding Raised
$148,091
Company Overview
Xironetic operates in Healthcare & Life Sciences and is based in Oklahoma City, Oklahoma. Its latest recorded funding round was a Grant round in May 2024.
Xironetic is a healthcare technology company that provides an FDA-cleared augmented reality platform, IntraOpVSP, which uses AI and computer vision to project holographic overlays onto a patient during surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, AR/VR Experiences, Computer Vision, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xironetic Comparables
Compare Xironetic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medivis | 87% | |
| MediView XR, Inc. | 85% | |
| EchoPixel, Inc. | 81% |
For institutional investors. Book with your work email.
Xironetic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 9, 2024 | ||||
| Accelerator | Jan 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Xironetic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| ASPS Innovation & Entrepreneurship Hub | Accelerator |
| United States Air Force | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 29, 2026
Grew 50% QoQ, from 8 to 12 employees.
- May 9, 2024
$148K grant received from government agencies.
For institutional investors. Book with your work email.
Xironetic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xironetic's valuation, stock price, and market status.
Is Xironetic a public or private company?
Xironetic is a private company.
What is the current stock price of Xironetic?
Xironetic is a private company, so its shares have no public market price. Caplight tracks Xironetic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xironetic worth (valuation)?
Valuation information for Xironetic is not publicly available.
Can I buy Xironetic stock?
Xironetic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xironetic's last funding round?
Xironetic's most recent funding round was Grant on May 9, 2024.
Who are the main investors in Xironetic?
Key investors in Xironetic include ASPS Innovation & Entrepreneurship Hub.
Will Xironetic IPO soon?
No public IPO plans have been announced for Xironetic.
How can I track Xironetic secondary market activity?
Caplight tracks bids, offers, and trades in Xironetic's shares on secondary markets.